Compare REYN & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | REYN | INDV |
|---|---|---|
| Founded | 1947 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Office Equipment/Supplies/Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 4.4B |
| IPO Year | 2019 | 2014 |
| Metric | REYN | INDV |
|---|---|---|
| Price | $24.65 | $39.75 |
| Analyst Decision | Hold | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $24.83 | N/A |
| AVG Volume (30 Days) | 983.1K | ★ 1.6M |
| Earning Date | 05-06-2026 | 06-08-2026 |
| Dividend Yield | ★ 4.47% | N/A |
| EPS Growth | N/A | ★ 8100.00 |
| EPS | 0.28 | ★ 0.69 |
| Revenue | ★ $3,756,000,000.00 | $1,239,000,000.00 |
| Revenue This Year | $1.91 | N/A |
| Revenue Next Year | $1.82 | N/A |
| P/E Ratio | $85.04 | ★ $55.54 |
| Revenue Growth | N/A | ★ 4.29 |
| 52 Week Low | $20.44 | $13.47 |
| 52 Week High | $26.25 | $41.00 |
| Indicator | REYN | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 75.59 | 65.46 |
| Support Level | $23.62 | $35.36 |
| Resistance Level | $24.69 | $41.00 |
| Average True Range (ATR) | 0.53 | 1.27 |
| MACD | 0.16 | 0.11 |
| Stochastic Oscillator | 99.38 | 98.69 |
Reynolds Consumer Products Inc is a provider of household products. The firm is engaged in the production and sales of cooking products, waste and storage products, and tableware. It operates through four reportable segments namely, Reynolds Cooking and Baking, Hefty Waste and Storage, Hefty Tableware, and Presto Products. Reynolds Cooking and Baking segment produce branded and store brand aluminum foil, disposable aluminum pans, parchment paper, freezer paper, wax paper, butcher paper, plastic wrap, baking cups, oven bags and slow cooker liners.
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).